ClariVest Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History

ClariVest Asset Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-45,000	Closed	-$419K	–	764
2019 Q2	$419K	Sell	45,000 -6,400	-12%	-$74.1K	0.01%	374
2019 Q1	$714K	Buy	51,400 +3,100	+6%	+$35.5K	0.01%	431
2018 Q4	$527K	Sell	48,300 -4,800	-9%	-$50.6K	0.01%	458
2018 Q3	$671K	Sell	53,100 -3,800	-7%	-$45.8K	0.01%	470
2018 Q2	$750K	Sell	56,900 -22,100	-28%	-$264K	0.01%	477
2018 Q1	$1.07M	Buy	79,000 +1,900	+2%	+$19.6K	0.02%	419
2017 Q4	$458K	Buy	77,100 +27,100	+54%	+$186K	0.01%	500
2017 Q3	$371K	Buy	50,000 +8,400	+20%	+$69.8K	0.01%	418
2017 Q2	$390K	Buy	+41,600	New	+$305K	0.01%	413

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClariVest Asset Management's CCXI Position: Q3 2019 in Review

ClariVest Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2019, closing a stake of 45,000 shares — an estimated $419K sold.

ClariVest Asset Management first reported a position in CCXI in Q2 2017 and held it in 9 quarters. The position peaked at $1.07M in Q1 2018. 100 funds tracked by Wall St. Rank hold CCXI as of Q3 2019.

ClariVest Asset Management reported no remaining ChemoCentryx, Inc. position as of Q3 2019 after selling out during the quarter.
ClariVest Asset Management sold 45,000 ChemoCentryx, Inc. shares in Q3 2019, an estimated $419K.
ClariVest Asset Management first reported a position in ChemoCentryx, Inc. in Q2 2017 and held it in 9 quarters.
ClariVest Asset Management's ChemoCentryx, Inc. position peaked at $1.07M in Q1 2018.
100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2019.

Based on ClariVest Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.